Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics),
Europe Western blotting market is anticipated to grow at a 5.3% CAGR from 2016 to 2021 and it is estimated that the Europe market was valued at USD 103.46 million in 2016 and is expected to reach USD 179.44 million by 2021.Western Blotting is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2016.
Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases.
Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.
Get a comprehensive overview of the Market: www.marketdataforecast.com/market-…ting-market-5088/
Increasing research activities and R&D spending by pharmaceutical and biotechnology companies and rise in the prevalence of HIV/AIDS are the primary driving factors of the market. Factors such as growth in proteomics market, the increasing number of industry-academic research collaborations, increase in requirement for personalized medicine, and new product launches are further expected to aid the growth of the market.
On the other hand, the emergence of alternative technologies is anticipated to have a negative impact on the growth of the market. Furthermore, strict regulations and requirement of high procedural efficiency for accurate results are likely to challenge the market in the coming years.
However, automation in western blotting instruments is expected to provide lucrative opportunities for the market.
Request for sample Brochure: www.marketdataforecast.com/market-…88/request-sample
The North-America market for Western Blotting market is segmented into Product, Application and End User. On the basis of product, it is segmented into Instruments and Consumables.
The consumables segment holds the largest share in this segment of the market. This is primarily due because of rise in the use of western blotting in research & diagnosis and increase in the number of incidences of diseases requiring western blotting for diagnosis.
The instruments market is further segmented into gel electrophoresis instruments, blotting systems, and images. The blotting systems segment is expected to account for the largest share in this market segment.
The large share of this segment can be credited to its high sensitivity, low run time, and high efficiency.
Inquire Before Buying: www.marketdataforecast.com/market-…rket-5088/inquire
On the basis of application, it is segmented into Biomedical & Biochemical Research and Disease Diagnostics. The biomedical & biochemical research segment is anticipated to hold the largest share of this market segment.
This is primarily due to the surge in government spending on proteomics research, and an increase in R&D spending by pharmaceutical & biotechnology companies in drug discovery and development. However, the disease diagnostics segment is projected to grow at the highest in the coming years.
This can be credited to rise in prevalence and incidences of HIV, HSV, HBV, and Lyme disease, among others. On the basis of end user, it is segmented into Academic & Research Institutes and Pharmaceutical & Biotechnology Companies.
Pharmaceutical and biotech companies segment will lead with the maximum share of this market segment. However, research institutions segment is anticipated to have the highest growth rate, followed by diagnostic laboratories segment with the smallest share in this market segment.
On the basis of geography, the market is analyzed under various regions namely Germany, U.K., France, Italy and Spain. Europe has the second largest share in the market.
This can be attributed to factors such as growth in proteomics market, the increasing number of industry-academic research collaborations, and increase in requirement for personalized medicine.
Some of the major companies dominating the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.
Gel Electrophoresis Instruments
Wet Blotting Systems
Semi-Dry Blotting Systems
Biomedical & Biochemical Research
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!